Prevent regulatory compliance issues and enhance research validity by identifying and addressing inclusion barriers before they affect your trial outcomes.
Are you concerned about ensuring your clinical trials represent and serve all relevant patient populations?
Most trial designs unintentionally create participation barriers for certain demographic groups, leading to skewed data, limited research validity, and potential regulatory challenges.
Ethics committees and funding bodies increasingly require evidence that trials consider factors such as age, gender, race, ethnicity, disability, sexual orientation, and socioeconomic status.
Our EIA consultants provide comprehensive assessments based on unrivalled experience across diverse therapeutic areas and patient populations.
We offer a completely free introductory discussion call to address your individual needs. Sign up by filling in the quick form here:
1. Initial scoping and planning — We assess your trial's objectives, target population, and potential group impacts
2. Data collection and analysis — We analyze demographic data and trial design to identify participation barriers
3. Stakeholder engagement — We involve patient advocacy groups and communities for crucial insights
4. Mitigation strategy development — We create practical solutions to address any adverse impacts identified
5. Monitoring and evaluation framework — We establish ongoing assessment systems to track progress and make adjustments
6. Comprehensive reporting — We deliver detailed documentation to support ethical approval and regulatory compliance
Download our comprehensive service brochure for detailed information on our methodology, case studies, and pricing:
Our thorough Equality Impact Assessments provide multiple advantages for your clinical research:
Everyone should have equal opportunity to benefit from clinical research advancements, regardless of their background or characteristics.